Supplementary Figure 4 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment Dahkki Wei Liu (20030)

Fáttát:

Supplementary Table 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment Dahkki Wei Liu (20030)

Fáttát:

Supplementary Figure 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment Dahkki Wei Liu (20030)

Fáttát:

Supplementary Figure7 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment Dahkki Wei Liu (20030)

Fáttát:

Supplementary Table S1 from Intratumoral CD16⁺ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1... Dahkki Hansol Lee (15054787)

Fáttát:

Supplementary Table S2 from Intratumoral CD16⁺ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1... Dahkki Hansol Lee (15054787)

Fáttát:

Supplementary Table S4 from Intratumoral CD16⁺ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1... Dahkki Hansol Lee (15054787)

Fáttát:

Supplementary Table S3 from Intratumoral CD16⁺ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1... Dahkki Hansol Lee (15054787)

Fáttát:

Supplementary Tables S1-7 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain... Dahkki James S. Wilmott (15008931)

Fáttát:

Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain M... Dahkki James S. Wilmott (15008931)

Fáttát:

Numerical values of data in Figs 1–6 and S1–S6 Figs. Dahkki Fengyi Mao (15073242)

Fáttát:

BTB domain and CNC homolog 1 (BACH1) is stabilized by Polo-like kinase 1 (PLK1). Dahkki Fengyi Mao (15073242)

Fáttát:

Knockdown of BTB domain and CNC homolog 1 (BACH1) impedes Polo-like kinase 1 (PLK1)-induced phenotype in melanoma. Dahkki Fengyi Mao (15073242)

Fáttát:

Overexpressed Polo-like kinase 1 (PLK1) promotes metastasis and metabolic reprogramming in melanoma. Dahkki Fengyi Mao (15073242)

Fáttát:

List of transcription factors associated with the top-regulated genes. Dahkki Fengyi Mao (15073242)

Fáttát:

Polo-like kinase 1 (PLK1) is involved in melanoma progression. Dahkki Fengyi Mao (15073242)

Fáttát:

Inhibition of Polo-like kinase 1 (PLK1) synergizes with Vemurafenib in the treatment of melanoma. Dahkki Fengyi Mao (15073242)

Fáttát:

Polo-like kinase 1 (PLK1) induces Vemurafenib resistance in melanoma. Dahkki Fengyi Mao (15073242)

Fáttát: